Fulgent Genetics, Inc. (FLGT) Tops Q4 EPS by $2.15, Revenues Rise 3400%; Raises Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. FIX
9. TSCO
10. BE

Go back to Fulgent Genetics, Inc. (FLGT) Tops Q4 EPS by $2.15, Revenues Rise 3400%; Raises Outlook

Fulgent Genetics Reports Record Fourth Quarter and Full Year 2020 Financial Results

March 4, 2021 4:05 PM EST

Fourth Quarter 2020 Results:

Record Revenue of $295.0 million, growing more than 3,400% year-over-yearRecord Billable tests delivered approximately 3.2 million, approximately 230 times the volume of fourth quarter of 2019Gross Margin improved over 8 percentage points sequentially and approximately 26 percentage points year-over-year; cost per test improved approximately 36% sequentiallyNon-COVID Revenue grew 43% year-over-yearRecord GAAP income of $166.3 million, or $6.16 per shareRecord Non-GAAP income of $167.5 million, or $6.20 per shareRecord Adjusted EBITDA of $230.1 million

2021 Outlook:

... More